Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Partitioned Training of Patients With Idiopathic Pulmonary Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03752892
Recruitment Status : Recruiting
First Posted : November 26, 2018
Last Update Posted : March 18, 2019
Sponsor:
Information provided by (Responsible Party):
Roger Goldstein, West Park Healthcare Centre

Brief Summary:
Idiopathic pulmonary fibrosis (IPF) is a lung disease that limits the ability to breathe enough for a good workout. One way to improve the exercise training is to reduce the number of muscles being trained together. By training one leg at a time, the patient does not have to breathe as much allowing each leg a better workout. Our groundwork suggests it may work in patients with IPF. This study will help decide whether one-legged exercise training is better at improving a patient's exercise endurance compared to the usual way of exercising with both legs at the same time.

Condition or disease Intervention/treatment Phase
Lung; Disease, Interstitial, With Fibrosis Other: intervention -1-leg cycle training Other: usual care - 2-leg cycle training Not Applicable

Detailed Description:

Dyspnea is a major clinical manifestation of idiopathic pulmonary fibrosis (IPF). It becomes more severe and more limiting as the condition progresses. Many professional respiratory societies recommend that the standard of care for IPF includes pulmonary rehabilitation (PR). However, some patients with IPF are so limited by dyspnea that they are unable to tolerate levels of aerobic exercise training sufficient to induce the physiological adaptations that will improve functional and health related outcomes. Therefore, there is a need for exercise training interventions that will enhance the muscle training stimulus above that currently possible in individuals with a marked ventilatory limitation.

Partitioning large muscle exercise using one-legged high intensity training is more effective than conventional aerobic training when applied to patients with central ventilatory or cardiac limitation. Effective partitioned exercise enables an increased muscle load with less ventilatory load. It increases the training stimulus to the muscles as they work at a high intensity, relative to their current aerobic state, necessary to increase their capacity. As long as the active muscle mass can create the same demands on the central exercise components of the heart and circulation as does conventional two-legged exercise, this simple, inexpensive novel approach, will stimulate leg muscles sufficiently to improve overall cardiorespiratory fitness. For example, in those with chronic obstructive pulmonary disease, one-legged training has been shown to provide a muscle specific stimulus sufficient to improve whole body peak oxygen uptake during pulmonary rehabilitation. A preliminary acute study of patients with IPF has demonstrated that during a laboratory simulation of an exercise training session, partitioning aerobic exercise extended exercise tolerance. Participants achieved double the work whilst exercising with one leg compared with two-legged cycle exercise. Partitioned training may therefore be an effective approach to exercise training in patients with IPF enrolled in PR.

The advent of pharmacological agents that stabilize the clinical course of IPF presents a window of opportunity for exercise rehabilitation to further improve function. The aim of this proposed study is to determine whether, within the setting of PR, partitioned aerobic exercise training with a one-legged cycle training regime is more effective than the conventional two-legged regimen in increasing exercise tolerance. The study hypothesis is that partitioned aerobic exercise training, using a one-legged training regime is more effective than conventional two-legged exercise training in increasing exercise tolerance (measured by constant power endurance) and cardiorespiratory fitness as measured by maximal oxygen uptake. The results will inform the best approach to produce clinically meaningful improvements in dyspnea and health status for those with IPF.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: prospective, randomized controlled trial
Masking: Single (Outcomes Assessor)
Masking Description: assessor of the primary outcomes will be blind to the participant's group allocation
Primary Purpose: Treatment
Official Title: Randomized Controlled Trial of Partitioned Aerobic Exercise Training of Patients With Idiopathic Pulmonary Fibrosis
Actual Study Start Date : March 1, 2019
Estimated Primary Completion Date : March 31, 2021
Estimated Study Completion Date : March 31, 2021


Arm Intervention/treatment
Experimental: intervention -1-leg cycle training
Primary aerobic training component one-legged, partitioned, cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity one-legged exercise progressing to continuous duration of the target duration of 15 min for each leg and then restarting the cycle at a higher intensity.
Other: intervention -1-leg cycle training
partitioned aerobic exercise training

Active Comparator: usual care - 2-leg cycle training
Primary aerobic training component conventional two-legged cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity exercise progressing to continuous duration of 30 min and then restarting the cycle at a higher intensity.
Other: usual care - 2-leg cycle training
conventional aerobic exercise training




Primary Outcome Measures :
  1. Cycle exercise endurance time [ Time Frame: Change from Baseline at discharge from 8 weeks of pulmonary rehabilitation ]
    tolerance (time) of a constant power high intensity cycle endurance test


Secondary Outcome Measures :
  1. health-related quality of life [ Time Frame: Change from Baseline at discharge from 8 weeks of pulmonary rehabilitation ]
    using the questionnaire 'A Tool to Assess Quality of life in IPF' [ATAQ-IPF]



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   45 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • confirmed idiopathic pulmonary fibrosis
  • Clinically stable
  • enrolled in pulmonary rehabilitation

Exclusion Criteria:

  • co-morbidities that might impair their ability to safely complete a pulmonary rehabilitation program
  • complete a pulmonary rehabilitation program within the previous 6 months
  • experienced an exacerbation less than six weeks before participation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03752892


Contacts
Layout table for location contacts
Contact: Tom Dolmage 1-416-243-3600 ext 2185 tom.dolmage@westpark.org

Locations
Layout table for location information
Canada, Ontario
West Park Healthcare Centre Recruiting
Toronto, Ontario, Canada, M6M 2J5
Contact: Tom Dolmage    4162433600    tom.dolmage@westpark.org   
Sponsors and Collaborators
West Park Healthcare Centre
Investigators
Layout table for investigator information
Principal Investigator: Roger S Goldstein West Park Healthcare Centre

Layout table for additonal information
Responsible Party: Roger Goldstein, Director, Program in Respiratory Rehabilitation, West Park Healthcare Centre
ClinicalTrials.gov Identifier: NCT03752892     History of Changes
Other Study ID Numbers: 1L-IPF-RCT-RG2018
First Posted: November 26, 2018    Key Record Dates
Last Update Posted: March 18, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Roger Goldstein, West Park Healthcare Centre:
pulmonary rehabilitation
exercise training
Additional relevant MeSH terms:
Layout table for MeSH terms
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Idiopathic Interstitial Pneumonias
Lung Diseases
Lung Diseases, Interstitial
Fibrosis
Pathologic Processes
Respiratory Tract Diseases